The U.S. Centers for Disease Control and Prevention has awarded researchers at Johns Hopkins University $2.1 million to evaluate how medication adherence technology and financial incentives affect recovery among patients being treated for opioid use disorder. Designed to investigate if a cash reward will improve the likelihood that patients stick to their medication plans, CEO of emocha Sebastian Seiguer calls this a “significant opportunity to study the use of our video technology for daily medication adherence paired with an immediate reward.” With previous engagement in other clinical validation studies, emocha’s technology has proven a scalable way to link patients to care. 

Read the article from Baltimore Business Journal